DCF Advisers’s Ovid Therapeutics OVID Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-11,750
| Closed | -$11K | – | 83 |
|
|
2024
Q4 | $11K | Sell |
11,750
-3,000
| -20% | -$2.8K | 0.01% | 80 |
|
|
2024
Q3 | $17.4K | Sell |
14,750
-27,000
| -65% | -$31.9K | 0.01% | 81 |
|
|
2024
Q2 | $32.1K | Buy |
41,750
+22,020
| +112% | +$16.9K | 0.02% | 83 |
|
|
2024
Q1 | $60.2K | Buy |
19,730
+1,000
| +5% | +$3.05K | 0.03% | 71 |
|
|
2023
Q4 | $60.3K | Sell |
18,730
-11,700
| -38% | -$37.7K | 0.03% | 67 |
|
|
2023
Q3 | $117K | Sell |
30,430
-34,334
| -53% | -$132K | 0.06% | 70 |
|
|
2023
Q2 | $212K | Sell |
64,764
-3,500
| -5% | -$11.5K | 0.11% | 68 |
|
|
2023
Q1 | $176K | Sell |
68,264
-2,000
| -3% | -$5.16K | 0.11% | 58 |
|
|
2022
Q4 | $131K | Sell |
70,264
-92,437
| -57% | -$172K | 0.09% | 57 |
|
|
2022
Q3 | $299K | Buy |
162,701
+21,000
| +15% | +$38.6K | 0.19% | 52 |
|
|
2022
Q2 | $305K | Hold |
141,701
| – | – | 0.18% | 48 |
|
|
2022
Q1 | $445K | Hold |
141,701
| – | – | 0.19% | 49 |
|
|
2021
Q4 | $455K | Hold |
141,701
| – | – | 0.18% | 53 |
|
|
2021
Q3 | $476K | Buy |
141,701
+2,000
| +1% | +$6.72K | 0.21% | 58 |
|
|
2021
Q2 | $546K | Buy |
139,701
+30,700
| +28% | +$120K | 0.19% | 55 |
|
|
2021
Q1 | $438K | Buy |
+109,001
| New | +$438K | 0.19% | 65 |
|